JO

Journal of Immunotherapy and Precision Oncology

Innovations Journals is a platform for timely dissemination of innovations in healthcare research and delivery and includes the Journal of Immunotherapy and Precision Oncology, which publishes continuously and is indexed in Web of Science (ESCI), PMC, Scopus, DOAJ, and Crossref.

Looking to publish in Journal of Immunotherapy and Precision Oncology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Existing customer login
Subject Immunology, Oncology
Impact Factor 3.2
Quartile Q2
Open Access Type Closed
ISSN 2666-2345
eISSN 2590-017X
Invitation Only No
Cost Range APC: $2400 USD for JIPO; optional CC BY license upgrade: $400.

Submission Instructions

Journal of Immunotherapy and Precision Oncology accepts the following article types. Click on an article type to view submission instructions.

Research Article

Cover Letter A cover letter is required as a separate doc, docx, or pdf file. The cover letter must state that all authors approved the manuscript, authorship requirements were met, the work is honest, and it must provide the corresponding author’s name, address, email, and telephone number.
Abstract A structured, informative abstract is required. The abstract must be 250-400 words. The abstract must be structured. The abstract must use the headings introduction, methods, results, and conclusion and include 3-5 keywords.
Manuscript The main text must be 3000-5000 words. The manuscript should be organized into Introduction, Methods, Results, Discussion, and Conclusion sections, with the discussion limited to 3-5 paragraphs and no more than 4 pages. The manuscript must include 3-5 keywords after the abstract and disclose any use of generative AI technology in the acknowledgment section, including the software name, version, and what was generated.
References Research Articles may include up to 50 references. References must follow AMA style. References must be numbered consecutively in order of first mention and use superscript Arabic numerals in square brackets after punctuation, with et al used after the third author only when there are more than four authors.
Figures & Tables Research Articles may include up to 6 tables and figures combined. Tables must be placed at the end of the manuscript after the references, and figures must be uploaded separately. Tables must be editable rather than embedded as images and each table must include a short self-explanatory title.
Reformat to Journal of Immunotherapy and Precision Oncology using Livewrite Premium

Review Article

Cover Letter Cover letter is required. Cover letter must state that all authors approved the manuscript, authorship requirements were met, the work is honest, and provide the corresponding author’s name, address, email, and telephone number.
Abstract Abstract is required. Abstract must be unstructured and 250-400 words. Abstract must be unstructured. Abstract must be a single paragraph followed by 3-5 keywords.
Manuscript Main text must not exceed 6000 words. Manuscript should generally be divided into Introduction, Methods, Results, Discussion, and Conclusion sections. Manuscript must include 3-5 keywords after the abstract and disclose any use of generative or AI-based technology in the acknowledgment section or methods section as appropriate, including the software name, version, and what was generated.
References References may include up to 100 sources. References must follow AMA style. References must be numbered consecutively in order of first mention and use et al after the 3rd author only when there are more than 4 authors.
Figures & Tables Review Articles may include up to 6 tables and figures combined. Tables must be placed at the end of the text after the references, and figures must be uploaded separately. Tables must be editable rather than embedded as images and each table must include a short self-explanatory title.
Reformat to Journal of Immunotherapy and Precision Oncology using Livewrite Premium

Guideline Article

Cover Letter Cover Letter requirements are not specified.
Abstract An abstract is required. The abstract must be 250-400 words. The abstract must be unstructured.
Manuscript The main text must be 3000-5000 words, with flexibility. The manuscript must present clear recommendations with levels of evidence and supporting references and use sound methodology with clear categorization of evidence. The abstract must be followed by 3-5 keywords, and any use of generative or AI-based technology for content creation must be disclosed in the manuscript or acknowledgment section with the software name, version, and what was generated.
References The manuscript may include up to 100 references, with flexibility. References must follow AMA style. References must be numbered consecutively in order of first mention and use et al after the 3rd author only if there are more than 4 authors.
Figures & Tables The manuscript may include up to 6 tables and figures combined, with flexibility. Tables must be placed at the end of the text after the references, and figures must be uploaded separately. Tables must be submitted in editable format rather than as images, and each figure legend must be listed on the last page of the manuscript file.
Reformat to Journal of Immunotherapy and Precision Oncology using Livewrite Premium

Consensus Article

Cover Letter A cover letter is required. Cover letter must state that all authors approved the manuscript, authorship requirements were met, and the work represents honest work, and it must provide the corresponding author’s name, address, email, and telephone number.
Abstract An abstract is required. Abstract must be 250 to 400 words. Abstract must be unstructured.
Manuscript Main text should be 3000 to 5000 words, with flexibility. Manuscript should generally be divided into Introduction, Methods, Results, Discussion, and Conclusion sections. Manuscript must include 3 to 5 keywords after the abstract and disclose any use of generative artificial intelligence software in the acknowledgment section with the software name, version, and what was generated by AI.
References References may include up to 100 entries, with flexibility. References must follow AMA style. References must be numbered consecutively in order of first mention and use superscript Arabic numerals in square brackets after punctuation marks.
Figures & Tables A maximum of 6 tables and figures combined may be included, with flexibility. Tables should be placed at the end of the text after the references, and figures must be uploaded separately. Tables must be submitted in editable format rather than as images, and figure legends must be listed on the last page of the manuscript file.
Reformat to Journal of Immunotherapy and Precision Oncology using Livewrite Premium

Brief Report

Cover Letter Cover letter is required as a separate file in doc, docx, or pdf format. Cover letter must include statements that all authors approved the manuscript, authorship requirements were met, the work is honest, and the corresponding author’s name, address, email, and telephone number.
Abstract Brief Reports require a short structured abstract. Abstract must be 100-250 words. Abstract must be structured. Abstract must use the headings introduction, methods, results, and conclusion.
Manuscript Main text must be up to 2500 words. Manuscript should not have subheadings. Abstract must be followed by 3-5 keywords, and any use of generative artificial intelligence software must be disclosed in the acknowledgment section with the software name, version, and what was generated.
References Brief Reports may include up to 20 references. References must follow AMA style. References must be numbered consecutively in order of first mention and use superscript Arabic numerals in square brackets after punctuation.
Figures & Tables Brief Reports may include up to 4 tables and figures combined. Tables must be placed at the end of the text after the references, and figures must be uploaded separately. Tables must be submitted in editable format rather than as images.
Reformat to Journal of Immunotherapy and Precision Oncology using Livewrite Premium

Case Report

Cover Letter Cover letter is required as a separate doc, docx, or pdf file. Cover letter must include statements that all authors approved the manuscript, authorship requirements were met, the work is honest, and the corresponding author's name, address, email, and telephone number are provided.
Abstract Case Reports must include an abstract. Abstract must be 100-250 words. Abstract must be short and unstructured.
Manuscript Main text must not exceed 2500 words. Case Reports must follow CARE guidelines. The manuscript must include an AI disclosure in the acknowledgment section naming the software, version, and generated content if generative AI was used.
References Case Reports may include up to 20 references. References must follow AMA style. References must be numbered consecutively in order of first mention, cited as Arabic numerals in superscript with square brackets after punctuation, and list et al after the third author only when there are more than four authors.
Figures & Tables Case Reports may include up to 4 tables and figures combined. Tables must be placed at the end of the text after the references, and figures must be uploaded separately. Tables must be editable rather than embedded as images, and each figure legend must be listed on the last page of the manuscript file.
Reformat to Journal of Immunotherapy and Precision Oncology using Livewrite Premium

Letter To The Editor

Cover Letter A cover letter is required as a separate doc, docx, or pdf file. The cover letter must state that all authors approved the manuscript, authorship requirements were met, the work is honest, and it must include the corresponding author’s name, address, email, and telephone number.
Abstract Abstract must not be included.
Manuscript Main text must be no more than 1500 words. Letters to the Editor should not use subheadings. Any use of generative artificial intelligence for content creation must be disclosed in the manuscript, including the software name, version, and what was generated.
References No more than 10 references may be included. References must follow AMA style. References must be numbered consecutively in order of first mention and use superscript Arabic numerals in square brackets after punctuation.
Figures & Tables Up to 1 table or figure may be included. Tables should be placed at the end of the text after the references, and figures must be uploaded separately. Tables must be inserted in editable format rather than as images, and each figure legend must be listed on the last page of the manuscript file.
Reformat to Journal of Immunotherapy and Precision Oncology using Livewrite Premium

Recent Publications

Evidence for Dose Optimization of Immune Checkpoint Inhibitors

Sewanti Limaye, Vanita Noronha, Kumar Prabhash

10.36401/jipo-26-x7
View Publication

Moving Beyond the Plateau in Immune Checkpoint Inhibition—The Imperative of Early Referral and Precision Strategies

Razelle Kurzrock

10.36401/jipo-26-x6
View Publication

The Immune Checkpoint Inhibitors Journey: From Early Promise to Lasting Impact

Joud Hajjar, Bettzy Stephen, Ashley E. Aaroe, Mazen M. Aiche, Nagham Al-Zubidi, May Ameri, Kaitlyn E. Aragon, Ivan Darin Carabenciov, Mark S. Chambers, Amina Lateef Chaudhry, Jean M. Connors, Michael A. Davies, Kala Chand Debnath, Saadia A. Faiz, Clifton D. Fuller, Ryan P. Goepfert, Dan S. Gombos, Shruti Gupta, Matthew Hadfield, Katherine A. Hutcheson, Shajedul Islam, Abdullah Jalal, Migara Jayasekera, Khalid A. Jazieh, Aye Khine, Peter Kim, Stephen Y. Lai, Yu Leo Lei, Yuanteng Jeff Li, Svetomir N. Markovic, Holly McMillan, Amy C. Moreno, Fiorinda Muhaj, Marc-Elie Nader, Adegbenga Otun, Omar Pacha, Nicolas L. Palaskas, Anisha B. Patel, Nimisha Patel, Zoe Quandt, Oded Sagiv, Elad Sharon, Malek Shatila, Ajay Sheshadri, Maria E. Suarez-Almazor, Anusha Shirwaikar Thomas, Yinghong Wang, Alex Won, Hao Chi Zhang, Aung Naing

10.36401/jipo-26-12
View Publication

Response to RAF/MEK/ERK Inhibitors in Patients with RAS-Altered and Wild-Type Tumors

Mohamed A. Gouda, Heather Lin, Lei Kang, Hung Le, Ecaterina E. Dumbrava, Siqing Fu, Daniel D. Karp, Apostolia Tsimberidou, Aung Naing, Sarina A. Piha-Paul, Paula Pohlmann, Jordi Rodon, Timothy A. Yap, Funda Meric-Bernstam, David S. Hong

10.36401/jipo-25-38
View Publication

From Promise to Precision: The Next Chapter of Checkpoint Inhibition

Kenji Chamoto, Tasuku Honjo, Shumei Kato

10.36401/jipo-26-x5
View Publication

Frequently asked questions

How long does it take to publish?

APCs must be paid within 7 days of acceptance to start production. Corrected proofs should be returned within 5 business days. Final approved articles are published online as soon as possible.

Reformat to Journal of Immunotherapy and Precision Oncology using Livewrite Premium

What are the publication costs?

Journal of Immunotherapy and Precision Oncology charges a $2400 USD article publication charge for accepted manuscripts. Authors may upgrade from the default CC BY-NC-ND license to CC BY for an additional $400.

Reformat to Journal of Immunotherapy and Precision Oncology using Livewrite Premium

Research Topics

Cancer Immunotherapy and Biomarkers Cancer Genomics and Diagnostics CAR-T cell therapy research Lung Cancer Treatments and Mutations Immunotherapy and Immune Responses Colorectal Cancer Treatments and Studies Lung Cancer Diagnosis and Treatment Immune Cell Function and Interaction Chronic Lymphocytic Leukemia Research PARP inhibition in cancer therapy Sarcoma Diagnosis and Treatment Lung Cancer Research Studies Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Economic and Financial Impacts of Cancer Lymphoma Diagnosis and Treatment Drug-Induced Adverse Reactions Protein Degradation and Inhibitors Colorectal and Anal Carcinomas Pancreatic and Hepatic Oncology Research Viral-associated cancers and disorders COVID-19 and healthcare impacts Melanoma and MAPK Pathways Acute Myeloid Leukemia Research HER2/EGFR in Cancer Research Brain Metastases and Treatment

Related Journals

JO
Journal of Hematology & Oncology BioMed Central
JO
Journal of Experimental & Clinical Cancer Research BioMed Central
EU
European Urology Oncology Elsevier BV
IR
Immunologic Research Springer Science+Business Media
JO
Journal of Inflammation Research Dove Medical Press
CJ
Chinese Journal of Cancer Research AME PUBLISHING COMPANY